1. 227 Predictive serum biomarkers in metastatic colorectal cancer patients treated in the BECOX trial with oxaliplatin-capecitabine (CAPOX) plus bevacizumab (GEMCAD 09-01). (September 2015) Authors: Pineda Losada, E.; Salud, A.; Vila-Navarro, E.; Safont, M.J.; Garcia-Giron, C.; Aparicio, J.; Vera, R.; Escudero, M.P.; Casado, E.; Bosch, C.; Bohn, U.; Perez Carrion, R.M.; Carmona Bayonas, A.; Ayuso, J.R.; Ripolles, T.; Bouzas, R.; Gironella, M.; Garcia-Albeniz, X.; Feliu, J.; Maurel, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗